We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Hormetic Effect of Metformin: "Less Is More"?
- Authors
Panfoli, Isabella; Puddu, Alessandra; Bertola, Nadia; Ravera, Silvia; Maggi, Davide
- Abstract
Metformin (MTF) is the first-line therapy for type 2 diabetes (T2DM). The euglycemic effect of MTF is due to the inhibition of hepatic glucose production. Literature reports that the principal molecular mechanism of MTF is the activation of 5′-AMP-activated protein kinase (AMPK) due to the decrement of ATP intracellular content consequent to the inhibition of Complex I, although this effect is obtained only at millimolar concentrations. Conversely, micromolar MTF seems to activate the mitochondrial electron transport chain, increasing ATP production and limiting oxidative stress. This evidence sustains the idea that MTF exerts a hormetic effect based on its concentration in the target tissue. Therefore, in this review we describe the effects of MTF on T2DM on the principal target organs, such as liver, gut, adipose tissue, endothelium, heart, and skeletal muscle. In particular, data indicate that all organs, except the gut, accumulate MTF in the micromolar range when administered in therapeutic doses, unmasking molecular mechanisms that do not depend on Complex I inhibition.
- Subjects
METFORMIN; TYPE 2 diabetes; ELECTRON transport; OXIDATIVE stress; ENDOTHELIUM; SKELETAL muscle; ADIPOSE tissues
- Publication
International Journal of Molecular Sciences, 2021, Vol 22, Issue 12, p6297
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms22126297